Tyzine and Urinary incontinence aggravated - a phase IV clinical study of FDA data

Summary:

Urinary incontinence aggravated is reported only by a few people who take Tyzine.

The phase IV clinical study analyzes which people take Tyzine and have Urinary incontinence aggravated. It is created by eHealthMe based on reports of 38 people who have side effects while taking Tyzine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

38 people reported to have side effects when taking Tyzine.
Among them, 2 people (5.26%) have Urinary incontinence aggravated.

What is Tyzine?

Tyzine has active ingredients of tetrahydrozoline hydrochloride. eHealthMe is studying from 42 Tyzine users for its effectiveness, alternative drugs and more.

What is Urinary incontinence aggravated?

Urinary incontinence aggravated (severe inability to control the flow of urine and involuntary urination) is found to be associated with 1,511 drugs and 407 conditions by eHealthMe.

Number of Tyzine and Urinary incontinence aggravated reports submitted per year:

Could Tyzine cause Urinary incontinence aggravated?

* Approximation only. Some reports may have incomplete information.

Do you take Tyzine and have Urinary incontinence aggravated?

Check whether Urinary incontinence aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Urinary incontinence aggravated and when was it recovered:

Urinary incontinence aggravated in Tyzine

Expand to all the drugs that have ingredients of tetrahydrozoline hydrochloride:

Urinary incontinence aggravated and drugs with ingredients of tetrahydrozoline hydrochloride

Alternative drugs to, pros and cons of Tyzine:

Tyzine (42 reports)

Urinary incontinence aggravated treatments and more:

Urinary incontinence aggravated (26 reports)

COVID vaccines that are related to Urinary incontinence aggravated:

Common drugs associated with Urinary incontinence aggravated:

All the drugs that are associated with Urinary incontinence aggravated:

Urinary incontinence aggravated (1,511 drugs)

Common conditions associated with Urinary incontinence aggravated:

Multiple sclerosis: 4,660 reports
High blood pressure: 1,702 reports
Pain: 1,415 reports
Depression: 1,376 reports
Osteoporosis: 1,369 reports
Rheumatoid arthritis: 984 reports
High blood cholesterol: 799 reports
Stress and anxiety: 774 reports
Gastroesophageal reflux disease: 749 reports

All the conditions that are associated with Urinary incontinence aggravated:

Urinary incontinence aggravated (407 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tetrahydrozoline hydrochloride (the active ingredients of Tyzine) and Tyzine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.